Zydus Lifesciences Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is DARUNAVIR, with a corresponding US DMF Number 33895.
Remarkably, this DMF maintains an Active status since its submission on May 29, 2019, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 19, 2019, and payment made on May 28, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II